During menopause, your nutritional needs may change. Here, get recommendations for foods that are rich in key nutrients to help ease menopause symptoms.

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

With Indian women reaching early menopause, it’s now more than a transition phase. Juggling a rollercoaster of emotions and high frequency changes in metabolism, the need for conversations and family ...

This article was reviewed by Julia Switzer, MD, FACOG. Key Takeaways: Menopause self-care includes physical, emotional, ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Growing evidence suggests this ancient spice can play a role in treating a wide range of health conditions Sue Quinn is an award-winning food journalist and cookbook author with almost 20 years ...

Eli Lilly (LLY) has built up its inventory for its experimental weight loss pill, orforglipron, as the Indiana-based pharma giant awaits a potential FDA approval for the oral GLP-1 drug over the ...

Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. Yahoo Racing is powered by Motorsport Network, providing expert reporting, analysis, and ...

Barbara Jacquelyn Sahakian receives funding from the Wellcome Trust and the Lundbeck Foundation. Her research work is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health ...

COPENHAGEN, Denmark — Novo Nordisk sued Hims and Hers Health on Monday over alleged patent infringement after the U.S. telehealth firm launched, then canceled, a $49 copy of Novo's weight-loss pill ...

Novo shares rise 5% after Hims scraps $49 weight‑loss pill FDA signals broader crackdown on compounded GLP-1 drugs Hims pulled its semaglutide-based pill after pushback Hims says lawsuit attacks ...